当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Hala Obiedat and Effat Ibrahim Al-Maaitah
Background: Pain is a subjective phenomenon, difficult to quantify and qualify, especially on neonates who are unable to self-report their pain which are gold standard of pain measurement in other age groups. The need for a pain measure is a clinically important for guiding pain management practices and evaluating the effectiveness of a particular intervention. Pain assessment tools have been developed and validated, but they are rarely used because they are too complicated.
Purpose: The aim of this integrative literature review was to critique the studies related of the use of Neonatal Infant Pain Scale (NIPS) to measure the pain as the fifth vital sign.
Method: Electronic searches were conducted using the following database: CINAHL, Science Direct, Pub Med and EBSCO. The search generated 40 articles; 30articles fit to the criteria of the integrative literature review.
Result: Neonatal Infant Pain Scale is multidimensional tool with sufficient psychometric prosperities because it had excellent inter rater reliability, concurrent validity, construct validity and predictive validity which should be essential for accurate assessment and appropriate interventions.
Conclusion: This review suggests implementing the NIPS scale as valid reliable tool to monitor pain routinely in the clinical practice, because it’s easily applied in comparison with other pain assessment tools.